Defendant
3 cases as defendant.
Bright Data, Ltd., often referred to as Bright Data, is a privately held Israeli technology company headquartered in Netanya, Israel. Founded in 2014 as Luminati Networks, the company rebranded to Bright Data in March 2021. It is backed by EMK Capital. Bright Data employs between 201 and 500 individuals, with estimates ranging from 314 to 415 employees. Annual revenue is estimated to be between $228.8 million and $300 million.
Bright Data operates as a global web data platform, providing services for web data collection and proxy networks. Its offerings include proxy networks (residential, datacenter, mobile, and ISP proxies with over 400 million IPs), web scraping tools such as Web Scraper API, Scraping Browser, Web Unlocker, and SERP API, and a marketplace for structured datasets. These solutions are used by over 20,000 organizations across various industries, including AI, e-commerce, finance, and market research, to access, monitor, and analyze public web data.
The company primarily exhibits an offensive patent litigation posture, with all two tracked cases listing Bright Data, Ltd. as the plaintiff and zero cases as a defendant. These cases are concentrated in the U.S. District Court for the Eastern District of Texas, a venue known for patent litigation. This pattern suggests Bright Data actively asserts its patent portfolio against competitors in its industry.
Notable cases include Bright Data, Ltd. v. Teso LT, UAB et al. and Bright Data, Ltd. v. Oxylabs, both filed in the Eastern District of Texas. In 2021, a federal jury found that Oxylabs (comprising Teso LT, UAB, Oxysales, UAB, and Metacluster LT, UAB) willfully infringed Bright Data's patents related to residential proxy solutions, awarding Bright Data lost profits. However, subsequent legal developments, including decisions by the U.S. Federal Circuit and the U.S. Patent Office, have upheld the invalidation of some of Bright Data's patents in disputes with Oxylabs and Code 200, UAB, impacting the standing of earlier infringement findings.
IPR petition challenging claims 1, 2, 6–11, 13, 15, 16, and 18–23 of U.S. Patent 11,044,342. The PTAB instituted on all challenged claims and grounds and issued a Final Written Decision on May 30, 2023 holding all challenged claims unpatentable.
Petitioners Code200, UAB, Teso LT, UAB, Metacluster LT, UAB, and Oxysales, UAB challenged claims 1, 2, 6–11, 13, 16, 18–25, 29–34, 36, 39, 41–46 of the '344 patent. The PTAB instituted on July 1, 2022, and issued a Final Written Decision holding all challenged claims unpatentable over Reiter et al.
A PTAB exhibit footer references Oxylabs, UAB v. Bright Data Ltd., IPR2024-00126, suggesting Oxylabs filed a second IPR against the '342 patent in 2024. The narrative could not confirm institution status, challenged claims, or outcome.